Fibrinogen as an early predictor of acute organ dysfunction in pelvic fractures

Po-Chun Wang1, Kuo-En Chen1, Hui-An Lin2

  • 1School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.

Injury
|December 19, 2025
PubMed

Insights

Low fibrinogen levels (≤200 mg/dL) in pelvic fracture patients predict higher mortality and organ dysfunction. This finding highlights fibrinogen as a critical prognostic marker in trauma care.

Area of Science:

  • Trauma Surgery
  • Hematology
  • Critical Care Medicine

Background:

  • Pelvic fractures are linked to significant morbidity and mortality.
  • The prognostic implications of initial fibrinogen levels in these patients are not well understood.

Purpose of the Study:

  • To investigate the prognostic value of initial fibrinogen levels in patients with pelvic fractures.
  • To determine the association between low fibrinogen levels and adverse outcomes, including mortality and organ dysfunction.

Main Methods:

  • Global retrospective cohort study using TriNetX Global Collaborative Network data (2005-2025).
  • Included patients with pelvic fractures and available fibrinogen levels, with ≥30 days follow-up.
  • Propensity score matching adjusted for covariates; compared outcomes for fibrinogen ≤200 mg/dL vs. >200.01 mg/dL.

Main Results:

  • 10,552 matched patients analyzed; low fibrinogen group showed significantly higher 30-day risks.
  • Increased risks observed for acute kidney injury (RR 1.30), shock (RR 1.51), respiratory failure (RR 1.29), ARDS (RR 1.28), DIC (RR 2.06), and all-cause mortality (RR 1.90).
  • Associations remained consistent across subgroups and sensitivity analyses.

Conclusions:

  • Fibrinogen level ≤200 mg/dL is a significant predictor of increased mortality.
  • Low fibrinogen is associated with heightened risk of acute organ dysfunction in pelvic fracture patients.
Abstract

Related Concept Videos

Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.3K
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
9.5K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
11.8K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
758
Introduction to Hemostasis01:05

Introduction to Hemostasis

Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
13.0K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
8.6K